Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
3,251
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness of brentuximab vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China

Jia Liua School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China;b Center for Social Science Survey and Data, Tianjin University, Tianjin, China
,
Lei Zhengc Takeda China, Shanghai, China
&
Ling-Hsiang Chuangd Umea University, Umea, Sweden;e GongJing Healthcare, Nanjing, ChinaCorrespondence[email protected]
Pages 99-107 | Received 18 May 2021, Accepted 16 Dec 2021, Published online: 12 Jan 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.